GLP-1 Receptor Agonist Use and Risk of Suicide Death

This cohort study assesses the association between use of glucagon-like peptide-1 receptor agonists and the risk of suicide death in routine clinical practice.

from JAMA Internal Medicine Online First https://ift.tt/VDg9SJr